Completed PHASE2 INTERVENTIONAL 2-arm NCT00202397

Effect of Riluzole as a Symptomatic Approach in Patients With Chronic Cerebellar Ataxia

Phase 2 Study of Riluzole Effects on Patients With Chronic Cerebellar Ataxia

Sponsor: S. Andrea Hospital

Conditions Cerebellar Ataxia Hereditary Ataxia Multiple Sclerosis

Updated 6 times since 2017 Last updated: Nov 27, 2024 Started: Jun 30, 2005 Primary completion: Jun 30, 2008 Completion: Aug 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00202397, this PHASE2 trial focuses on Cerebellar Ataxia and Hereditary Ataxia and remains completed. Sponsored by S. Andrea Hospital, it has been updated 6 times since 2005, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Dec 2024 — Present [monthly]

Completed PHASE2
Sep 2024 — Dec 2024 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Jun 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

S. Andrea Hospital

Data source: S. Andrea Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Rome, Italy